Cargando…

Variations of SARS-CoV-2 in the Iranian population and candidate putative drug-like compounds to inhibit the mutated proteins

The first cases of the novel coronavirus, SARS-CoV-2, were detected in December 2019 in Wuhan, China. Nucleotide substitutions and mutations in the SARS-CoV-2 sequence can result in the evolution of the virus and its rapid spread across the world. Therefore, understanding genetic variants of SARS-Co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mortezaei, Zahra, Mohammadian, Ali, Tavallaei, Mahmood
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271419/ https://www.ncbi.nlm.nih.gov/pubmed/35847618 http://dx.doi.org/10.1016/j.heliyon.2022.e09910

Ejemplares similares

Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
por: Girgis, Adel S., et al.
Publicado: (2023)

Bio-activity prediction of drug candidate compounds targeting SARS-Cov-2 using machine learning approaches
por: Ashraf, Faisal Bin, et al.
Publicado: (2023)

SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions
por: Timmers, Luis Fernando Saraiva Macedo, et al.
Publicado: (2021)

Candidate drugs against SARS-CoV-2 and COVID-19
por: McKee, Dwight L., et al.
Publicado: (2020)

Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance
por: Loiseau, P.M., et al.
Publicado: (2011)

Investigation of angucycline compounds as potential drug candidates against SARS Cov-2 main protease using docking and molecular dynamic approaches
por: Al-Bustany, Hazem Abbas, et al.
Publicado: (2021)

Identification of Putative Precursor Genes for the Biosynthesis of Cannabinoid-Like Compound in Radula marginata
por: Hussain, Tajammul, et al.
Publicado: (2018)

Early Drug Development and Evaluation of Putative Antitubercular Compounds in the -Omics Era
por: Minias, Alina, et al.
Publicado: (2021)

Variation in volatile organic compounds in fruits of Iranian Capparis spinosa L. accessions
por: Alipour, Fereidon, et al.
Publicado: (2021)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

Mapping and identification of CsUp, a gene encoding an Auxilin-like protein, as a putative candidate gene for the upward-pedicel mutation (up) in cucumber
por: Sun, Jingxian, et al.
Publicado: (2019)

Marine drugs as putative inhibitors against non-structural proteins of SARS-CoV-2: an in silico study
por: Patel, Simran, et al.
Publicado: (2023)

A comprehensive overview of identified mutations in SARS CoV-2 spike glycoprotein among Iranian patients
por: Eslami, Solat, et al.
Publicado: (2022)

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
por: Jeon, Sangeun, et al.
Publicado: (2020)

Phenolic Compounds as Promising Drug Candidates in Tuberculosis Therapy
por: Mazlun, Muhamad Harith, et al.
Publicado: (2019)

Structural analysis of the putative SARS-CoV-2 primase complex
por: Konkolova, Eva, et al.
Publicado: (2020)

Tracking and curating putative SARS-CoV-2 recombinants with RIVET
por: Smith, Kyle, et al.
Publicado: (2023)

Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning
por: Ackerman, Emily E., et al.
Publicado: (2020)

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates
por: Ye, Gang, et al.
Publicado: (2021)

Compound Heterozygosity for Two Novel SLC26A4 Mutations in a Large Iranian Pedigree with Pendred Syndrome
por: Yazdanpanahi, Nasrin, et al.
Publicado: (2013)

Identification of potent compounds against SARs-CoV-2: An in-silico based drug searching against Mpro
por: Hassam, Muhammad, et al.
Publicado: (2022)

Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis
por: Portelli, Stephanie, et al.
Publicado: (2018)

(Q)SAR Models of HIV-1 Protein Inhibition by Drug-Like Compounds
por: Stolbov, Leonid A., et al.
Publicado: (2019)

Computational models identify several FDA approved or experimental drugs as putative agents against SARS-CoV-2
por: Bobrowski, Tesia, et al.
Publicado: (2020)

Potential anti‐SARS‐CoV‐2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease
por: Tsuji, Motonori
Publicado: (2020)

A Putative Prophylactic Solution for COVID-19: Development of Novel Multiepitope Vaccine Candidate against SARS-COV-2 by Comprehensive Immunoinformatic and Molecular Modelling Approach
por: Rehman, Hafiz Muzzammel, et al.
Publicado: (2020)

Computational screening for potential drug candidates against the SARS-CoV-2 main protease
por: Silva Andrade, Bruno, et al.
Publicado: (2020)

Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study
por: Nag, Anish, et al.
Publicado: (2021)

Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections
por: Reinke, Patrick Y. A., et al.
Publicado: (2023)

Aberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor Tissues
por: Damavandi, Zahra, et al.
Publicado: (2016)

Mutations of the phenylalanine hydroxylase gene in Iranian patients with phenylketonuria
por: Biglari, Alireza, et al.
Publicado: (2015)

Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates
por: García-Estrada, Carlos, et al.
Publicado: (2023)

In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19
por: Mirmohammadi, SeyedehMozhdeh, et al.
Publicado: (2022)

TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds
por: Haga, Shiori, et al.
Publicado: (2010)

Identification of novel mutations in SARS-COV-2 isolates from Turkey
por: Rehman, Shazia, et al.
Publicado: (2020)

The structure-based design of peptidomimetic inhibitors against SARS-CoV-2 3C like protease as Potent anti-viral drug candidate
por: Wang, Hao, et al.
Publicado: (2022)

Distinct genetic variation and heterogeneity of the Iranian population
por: Mehrjoo, Zohreh, et al.
Publicado: (2019)

AI-Driven De Novo Design and Molecular Modeling for Discovery of Small-Molecule Compounds as Potential Drug Candidates Targeting SARS-CoV-2 Main Protease
por: Andrianov, Alexander M., et al.
Publicado: (2023)

Synthesis and In Silico Docking Study towards M-Pro of Novel Heterocyclic Compounds Derived from Pyrazolopyrimidinone as Putative SARS-CoV-2 Inhibitors
por: Horchani, Mabrouk, et al.
Publicado: (2022)

Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations
por: Tiezzi, Camilla, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ngvlguri7niua1brfgfv7dpjii